These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26514912)

  • 1. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
    Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
    COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long-Acting β
    Ferroni E; Belleudi V; Cascini S; Di Martino M; Kirchmayer U; Pistelli R; Patorno E; Formoso G; Fusco D; Perucci CA; Davoli M; Agabiti N;
    J Clin Pharmacol; 2016 Nov; 56(11):1423-1432. PubMed ID: 27095425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.
    Belleudi V; Di Martino M; Cascini S; Kirchmayer U; Pistelli R; Formoso G; Fusco D; Davoli M; Agabiti N;
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1295-1304. PubMed ID: 27396695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.
    Di Martino M; Agabiti N; Bauleo L; Kirchmayer U; Cascini S; Pistelli R; Colamesta V; Patorno E; Pinnarelli L; Fusco D; Perucci CA; Davoli M;
    COPD; 2014 Aug; 11(4):414-23. PubMed ID: 24090036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
    Busch R; Han MK; Bowler RP; Dransfield MT; Wells JM; Regan EA; Hersh CP;
    BMC Pulm Med; 2016 Feb; 16():28. PubMed ID: 26861867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease.
    Arfè A; Nicotra F; Cerveri I; de Marco R; Vaghi A; Merlino L; Corrao G
    COPD; 2016 Oct; 13(5):540-6. PubMed ID: 26934569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD.
    Yamauchi Y; Yasunaga H; Hasegawa W; Sakamoto Y; Takeshima H; Jo T; Matsui H; Fushimi K; Nagase T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1403-11. PubMed ID: 27382276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.
    Manoharan A; Short PM; Anderson WJ; Lipworth BJ
    Lung; 2014 Oct; 192(5):649-52. PubMed ID: 24952426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
    Short PM; Williamson PA; Elder DHJ; Lipworth SIW; Schembri S; Lipworth BJ
    Chest; 2012 Jan; 141(1):81-86. PubMed ID: 21799028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD009039. PubMed ID: 21901729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.
    Contoli M; Campo G; Pavasini R; Marchi I; Pauletti A; Balla C; Spanevello A; Ferrari R; Papi A
    Eur J Intern Med; 2018 Jan; 47():82-86. PubMed ID: 28821412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A
    Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study.
    Suissa S; Dell'Aniello S; Ernst P
    Chest; 2017 Jan; 151(1):60-67. PubMed ID: 27554300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.